121 related articles for article (PubMed ID: 26289838)
1. Efficacy of estrogen replacement therapy (ERT) on uterine growth and acquisition of bone mass in patients with Turner syndrome.
Nakamura T; Tsuburai T; Tokinaga A; Nakajima I; Kitayama R; Imai Y; Nagata T; Yoshida H; Hirahara F; Sakakibara H
Endocr J; 2015; 62(11):965-70. PubMed ID: 26289838
[TBL] [Abstract][Full Text] [Related]
2. The Efficacy of Long-Term Estrogen Replacement Therapy in Turner Syndrome Women with Premature Ovarian Insufficiency.
Son KA; Lee DY; Yoon BK; Choi D
J Pediatr Adolesc Gynecol; 2019 Oct; 32(5):530-534. PubMed ID: 31145987
[TBL] [Abstract][Full Text] [Related]
3. Eldecalcitol increases bone mass in patients with Turner syndrome who have insufficient bone mass acquisition after estrogen replacement therapy.
Tsuburai T; Nakamura T; Yoshikata H; Miyagi E; Sakakibara H
Endocr J; 2018 Jun; 65(6):629-638. PubMed ID: 29607913
[TBL] [Abstract][Full Text] [Related]
4. The importance of estrogen replacement in young women with Turner syndrome.
Hanton L; Axelrod L; Bakalov V; Bondy CA
J Womens Health (Larchmt); 2003 Dec; 12(10):971-7. PubMed ID: 14709185
[TBL] [Abstract][Full Text] [Related]
5. Estrogen requirements in girls with Turner syndrome; how low is enough for initiating puberty and uterine development?
Kim NY; Lee DY; Kim MJ; Yoon BK; Choi D
Gynecol Endocrinol; 2012 Feb; 28(2):130-3. PubMed ID: 21793702
[TBL] [Abstract][Full Text] [Related]
6. Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome.
Cleemann L; Hjerrild BE; Lauridsen AL; Heickendorff L; Christiansen JS; Mosekilde L; Gravholt CH
Eur J Endocrinol; 2009 Aug; 161(2):251-7. PubMed ID: 19447901
[TBL] [Abstract][Full Text] [Related]
7. Estrogen therapy initiated at an early age increases bone mineral density in Turner syndrome patients.
Kodama M; Komura H; Kodama T; Nishio Y; Kimura T
Endocr J; 2012; 59(2):153-9. PubMed ID: 22139404
[TBL] [Abstract][Full Text] [Related]
8. Effects of age at estrogen replacement therapy initiation on trabecular bone score in Japanese adults with Turner syndrome.
Saito S; Koga E; Okada Y; Tsuburai T; Yoshikata H; Miyagi E; Sakakibara H
Osteoporos Int; 2021 Apr; 32(4):671-680. PubMed ID: 32968889
[TBL] [Abstract][Full Text] [Related]
9. The Effect of the Rate of Increase of Estrogen Replacement Therapy on Bone Mineral Density Accrual in Young Patients with Turner Syndrome.
Brander EPA; Keenahan LA; Sangi-Haghpeykar H; Graham M; Dietrich JE
J Pediatr Adolesc Gynecol; 2023 Aug; 36(4):353-357. PubMed ID: 36934800
[TBL] [Abstract][Full Text] [Related]
10. Conjugated oral versus transdermal estrogen replacement in girls with Turner syndrome: a pilot comparative study.
Nabhan ZM; Dimeglio LA; Qi R; Perkins SM; Eugster EA
J Clin Endocrinol Metab; 2009 Jun; 94(6):2009-14. PubMed ID: 19318455
[TBL] [Abstract][Full Text] [Related]
11. Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients.
Carrascosa A; Gussinyé M; Terradas P; Yeste D; Audí L; Vicens-Calvet E
J Bone Miner Res; 2000 Oct; 15(10):2005-10. PubMed ID: 11028454
[TBL] [Abstract][Full Text] [Related]
12. Uterine Development During Induced Puberty in Girls with Turner Syndrome.
Obara-Moszynska M; Dzialach L; Rabska-Pietrzak B; Niedziela M; Kapczuk K
Front Endocrinol (Lausanne); 2021; 12():707031. PubMed ID: 34295308
[TBL] [Abstract][Full Text] [Related]
13. Starting age of oestrogen-progestin therapy is negatively associated with bone mineral density in young adults with Turner syndrome independent of age and body mass index.
Nishigaki S; Itonaga T; Hasegawa Y; Kawai M
Clin Endocrinol (Oxf); 2021 Jul; 95(1):84-91. PubMed ID: 33872421
[TBL] [Abstract][Full Text] [Related]
14. A retrospective multicenter study of bone mineral density in adolescents and adults with Turner syndrome in Japan.
Itonaga T; Koga E; Nishigaki S; Kawai M; Sakakibara H; Hasegawa Y
Endocr J; 2020 Oct; 67(10):1023-1028. PubMed ID: 32554947
[TBL] [Abstract][Full Text] [Related]
15. Predicting the effects of estrogen replacement therapy on lumbar bone mineral density in oophorectomized women: analysis of a 10-year longitudinal study.
Nagata H; Nozaki M; Nakano H
Osteoporos Int; 2003 Nov; 14(11):905-12. PubMed ID: 14534773
[TBL] [Abstract][Full Text] [Related]
16. Volumetric bone mineral density in young women with Turner's syndrome treated with estrogens or estrogens plus growth hormone.
Bertelloni S; Cinquanta L; Baroncelli GI; Simi P; Rossi S; Saggese G
Horm Res; 2000; 53(2):72-6. PubMed ID: 10971092
[TBL] [Abstract][Full Text] [Related]
17. Effects of Estrogen Therapies on Outcomes in Turner Syndrome: Assessment of Induction of Puberty and Adult Estrogen Use.
Cameron-Pimblett A; Davies MC; Burt E; Talaulikar VS; La Rosa C; King TFJ; Conway GS
J Clin Endocrinol Metab; 2019 Jul; 104(7):2820-2826. PubMed ID: 30726925
[TBL] [Abstract][Full Text] [Related]
18. Uterine Development After Estrogen Replacement Therapy in Women with Different Etiologies of Primary Hypogonadism.
Kim HJ; Lee DY; Yoon BK; Choi D
J Pediatr Adolesc Gynecol; 2016 Aug; 29(4):344-7. PubMed ID: 26639994
[TBL] [Abstract][Full Text] [Related]
19. Turner syndrome adolescents receiving growth hormone are not osteopenic.
Neely EK; Marcus R; Rosenfeld RG; Bachrach LK
J Clin Endocrinol Metab; 1993 Apr; 76(4):861-6. PubMed ID: 8473397
[TBL] [Abstract][Full Text] [Related]
20. Bone mineralization in Turner syndrome: a transverse study of the determinant factors in 58 patients.
Costa AM; Lemos-Marini SH; Baptista MT; Morcillo AM; Maciel-Guerra AT; Guerra G
J Bone Miner Metab; 2002; 20(5):294-7. PubMed ID: 12203035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
